Management of pediatric snake bites: are we doing too much?

[1]  W. Richardson,et al.  Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop , 2011, BMC emergency medicine.

[2]  D. Warrell,et al.  Commissioned article: management of exotic snakebites. , 2009, QJM : monthly journal of the Association of Physicians.

[3]  C. Goto,et al.  Crotalidae Polyvalent Immune Fab for the Treatment of Pediatric Crotaline Envenomation , 2009, Pediatric emergency care.

[4]  W. Banner,et al.  Utilisation of Crotalidae polyvalent immune fab (ovine) for Viperidae envenomations in children , 2008, Emergency Medicine Journal.

[5]  A. Kasturiratne,et al.  The Global Burden of Snakebite: A Literature Analysis and Modelling Based on Regional Estimates of Envenoming and Deaths , 2008, PLoS medicine.

[6]  R. Jackson,et al.  Pediatric snakebites: lessons learned from 114 cases. , 2008, Journal of pediatric surgery.

[7]  D. Morgan,et al.  Texas Coral Snake (Micrurus tener) Bites , 2007, Southern medical journal.

[8]  J. Calvete,et al.  Snake venomics: Characterization of protein families in Sistrurus barbouri venom by cysteine mapping, N‐terminal sequencing, and tandem mass spectrometry analysis , 2004, Proteomics.

[9]  R. Dart,et al.  Bites of venomous snakes. , 2002, The New England journal of medicine.

[10]  P. Wax,et al.  Initial postmarketing experience with crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation. , 2002, Annals of emergency medicine.

[11]  R. Dart,et al.  Efficacy, safety, and use of snake antivenoms in the United States. , 2001, Annals of emergency medicine.

[12]  E. Hall.  Role of surgical intervention in the management of crotaline snake envenomation. , 2001, Annals of emergency medicine.

[13]  H. Persson.  Envenoming by European vipers antivenom treatment--influence on morbidity. , 2001, Przeglad lekarski.

[14]  J. Gutiérrez,et al.  Snake venom metalloproteinases: their role in the pathogenesis of local tissue damage. , 2000, Biochimie.

[15]  S. Corbett,et al.  Rattlesnake venom-induced thrombocytopenia response to Antivenin (Crotalidae) Polyvalent: a case series. , 2000, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[16]  S. Nelson,et al.  Antibiotic Prophylaxis for Pit Viper Envenomation: Prospective, Controlled Trial , 1997, World Journal of Surgery.

[17]  R. Langley,et al.  Deaths resulting from animal attacks in the United States. , 1997, Wilderness & environmental medicine.

[18]  K. Hurlbut,et al.  Validation of a severity score for the assessment of crotalid snakebite. , 1996, Annals of emergency medicine.

[19]  D. Smith,et al.  Comparison of a new ovine antigen binding fragment (Fab) antivenin for United States Crotalidae with the commercial antivenin for protection against venom-induced lethality in mice. , 1995, The American journal of tropical medicine and hygiene.

[20]  R. Clark,et al.  The incidence of wound infection following crotalid envenomation. , 1993, The Journal of emergency medicine.

[21]  W. Wingert,et al.  Rattlesnake bites in southern California and rationale for recommended treatment. , 1988, The Western journal of medicine.

[22]  C. Kitchens,et al.  Envenomation by the Eastern coral snake (Micrurus fulvius fulvius). A study of 39 victims. , 1987, JAMA.

[23]  F. Russell,et al.  CLINICAL REACTIONS TO ANTIVENIN , 1978 .